Wolfram Klapper
Impact in
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 39
- Genetic factors in colorectal cancer 4
- Genetics 13
- Chronic Lymphocytic Leukemia Research 13
- Co-authors
- Wolfgang Hiddemann (23 shared papers)Michael Unterhalt (15 shared papers)Martin H. Dreyling (15 shared papers)Eva Hoster (15 shared papers)Hanneke C. Kluin‐Nelemans (4 shared papers)Achiel Van Hoof (3 shared papers)Marcel Reiser (2 shared papers)Hartmut Eimermacher (2 shared papers)
In The Last Decade
Wolfram Klapper
39 papers receiving 3.8k citations
Wolfram Klapper's Hit Papers
Peers
Comparison fields: 5 of 72
- Pathology and Forensic Medicine 3.2k
- Genetics 1.3k
- Oncology 2.0k
- Reproductive Medicine 223
- Neurology 290
Countries citing papers authored by Wolfram Klapper
This map shows the geographic impact of Wolfram Klapper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram Klapper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram Klapper more than expected).
Fields of papers citing papers by Wolfram Klapper
This network shows the impact of papers produced by Wolfram Klapper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram Klapper. The network helps show where Wolfram Klapper may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfram Klapper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Hit paper breakdown → | 2007 | 761 |
| 2 | Obinutuzumab for the First-Line Treatment of Follicular Lymphoma Hit paper breakdown → | 2017 | 597 |
| 3 | Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry Hit paper breakdown → | 2015 | 514 |
| 4 | 2016 | 279 | |
| 5 | 2009 | 223 | |
| 6 | 2016 | 192 | |
| 7 | 2007 | 188 | |
| 8 | 2009 | 141 | |
| 9 | 2014 | 134 | |
| 10 | 2008 | 121 | |
| 11 | 2012 | 77 | |
| 12 | 2020 | 66 | |
| 13 | 2018 | 56 | |
| 14 | 2016 | 52 | |
| 15 | 2007 | 52 | |
| 16 | 2021 | 42 | |
| 17 | 2016 | 39 | |
| 18 | 2015 | 37 | |
| 19 | 2017 | 37 | |
| 20 | 2012 | 32 |
About Wolfram Klapper
Wolfram Klapper is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Reproductive Medicine, having authored 41 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (39 papers), Viral-associated cancers and disorders (14 papers), Chronic Lymphocytic Leukemia Research (13 papers), Genetic factors in colorectal cancer (4 papers), Immune Cell Function and Interaction (4 papers), Ovarian cancer diagnosis and treatment (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.2k citations), Genetics (1.3k citations), Oncology (2.0k citations), Reproductive Medicine (223 citations) and Neurology (290 citations). Wolfram Klapper has collaborated with scholars based in Germany, France and Canada. Frequent co-authors include Wolfgang Hiddemann, Michael Unterhalt, Martin H. Dreyling, Eva Hoster, Hanneke C. Kluin‐Nelemans, Achiel Van Hoof, Marcel Reiser, Hartmut Eimermacher, Bernd Metzner and Marek Trněný. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Blood Advances and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.